Susquehanna International Group
WVE icon

Susquehanna International Group’s Wave Life Sciences WVE Stock Holding History

Susquehanna International Group’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.74M Sell
240,600
-393,500
-62% -$5.13M ﹤0.01% 6492
2025
Q4 		$10.8M Buy
634,100
+620,300
+4,495% +$6.3M ﹤0.01% 2942
2025
Q3 		$101K Buy
+13,800
New +$112K ﹤0.01% 11557
2025
Q2 		– Sell
-81,700
Closed -$660K – 13834
2025
Q1 		$660K Sell
81,700
-21,100
-21% -$231K ﹤0.01% 8289
2024
Q4 		$1.27M Buy
102,800
+19,400
+23% +$259K ﹤0.01% 6384
2024
Q3 		$684K Buy
83,400
+41,900
+101% +$250K ﹤0.01% 7715
2024
Q2 		$207K Buy
41,500
+28,700
+224% +$164K ﹤0.01% 10282
2024
Q1 		$79K Sell
12,800
-1,400
-10% -$7.01K ﹤0.01% 11343
2023
Q4 		$71.7K Buy
+14,200
New +$75.9K ﹤0.01% 11534
2023
Q1 		– Sell
-11,200
Closed -$78.4K – 13596
2022
Q4 		$78.4K Buy
+11,200
New +$51.6K ﹤0.01% 11141
2021
Q4 		– Sell
-11,700
Closed -$57K – 14015
2021
Q3 		$57K Sell
11,700
-47,500
-80% -$288K ﹤0.01% 12306
2021
Q2 		$394K Sell
59,200
-341,900
-85% -$2.23M ﹤0.01% 10170
2021
Q1 		$2.25M Buy
401,100
+375,300
+1,455% +$3.61M ﹤0.01% 5636
2020
Q4 		$203K Sell
25,800
-100,700
-80% -$845K ﹤0.01% 10017
2020
Q3 		$1.07M Buy
126,500
+28,600
+29% +$313K ﹤0.01% 5940
2020
Q2 		$1.02M Buy
97,900
+23,500
+32% +$221K ﹤0.01% 5874
2020
Q1 		$697K Sell
74,400
-159,900
-68% -$1.36M ﹤0.01% 6207
2019
Q4 		$1.88M Buy
234,300
+193,800
+479% +$4.75M ﹤0.01% 4433
2019
Q3 		$831K Buy
40,500
+7,300
+22% +$167K ﹤0.01% 6108
2019
Q2 		$866K Buy
33,200
+300
+0.9% +$8.41K ﹤0.01% 6007
2019
Q1 		$1.28M Buy
+32,900
New +$1.33M ﹤0.01% 4536

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Susquehanna International Group's WVE Position: Q1 2026 in Review

Susquehanna International Group reduced its Wave Life Sciences (WVE) stake by 31% in Q1 2026, selling an estimated $1.55M and leaving 259,825 shares worth $1.88M. The position accounts for ﹤0.01% of the portfolio, ranked #6318.

Susquehanna International Group first reported a position in WVE in Q1 2016 and has held it in 25 quarters since. The position peaked at $6.44M in Q4 2025. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • Susquehanna International Group held 259,825 shares of Wave Life Sciences worth $1.88M as of Q1 2026.
  • Susquehanna International Group sold 119,162 Wave Life Sciences shares in Q1 2026, an estimated $1.55M.
  • Wave Life Sciences made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #6318 holding.
  • Susquehanna International Group first reported a position in Wave Life Sciences in Q1 2016 and has held it in 25 quarters since.
  • Susquehanna International Group's Wave Life Sciences position peaked at $6.44M in Q4 2025.
  • 230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.